Literature DB >> 11790291

Genetic determinants of vascular reactivity.

Daniel Henrion1, Joelle Benessiano, Marc Iglarz, Ivan Philip, Bernard I Levy.   

Abstract

Blood pressure is controlled by a complex combination of processes that influence cardiac output and peripheral vascular resistance. Multiple genes potentially influence each parameter involved in the control of blood pressure, and individuals with the same blood pressor level do not necessarily have the same genotype at relevant loci, nor do individuals with the same genotype at particular loci necessarily have the same blood pressure. Nevertheless, pharmacogenetic studies of vascular reactivity will certainly allow the analysis of the mechanisms affected by genes, and lead to a better understanding of the epidemiologic observations seen in large groups of patients. Polymorphisms in the genes of the renin-angiotensin system allow definition of the "genetic profile" associated with a higher risk of cardiovascular disease, and can also be linked to significant changes in vascular reactivity in arteries isolated from patients carrying the polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790291     DOI: 10.1007/s11906-002-0052-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  55 in total

Review 1.  Signaling mechanisms underlying the vascular myogenic response.

Authors:  M J Davis; M A Hill
Journal:  Physiol Rev       Date:  1999-04       Impact factor: 37.312

2.  Influence of the M235T polymorphism of human angiotensinogen (AGT) on plasma AGT and renin concentrations after ethinylestradiol administration.

Authors:  M Azizi; M C Hallouin; X Jeunemaitre; T T Guyene; J Ménard
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

3.  Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease.

Authors:  B R Winkelmann; A P Russ; M Nauck; B Klein; B O Böhm; V Maier; R Zotz; G Matheis; A Wolf; H Wieland; W Gross; D J Galton; W März
Journal:  Am Heart J       Date:  1999-04       Impact factor: 4.749

Review 4.  Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease.

Authors:  J G Wang; J A Staessen
Journal:  Eur J Pharmacol       Date:  2000-12-27       Impact factor: 4.432

5.  The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction.

Authors:  C Amant; M Hamon; C Bauters; F Richard; N Helbecque; E P McFadden; X Escudero; J M Lablanche; P Amouyel; M E Bertrand
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

6.  Pressor and hormonal responses to angiotensin I infusion in healthy subjects of different angiotensin-converting enzyme genotypes.

Authors:  I G Chadwick; L O'Toole; A H Morice; W W Yeo; P R Jackson; L E Ramsay
Journal:  J Cardiovasc Pharmacol       Date:  1997-04       Impact factor: 3.105

7.  Endothelial cell damage and angiotensin-converting enzyme insertion/deletion genotype in elderly hypertensive patients.

Authors:  K Kario; T Matsuo; H Kobayashi; N Kanai; S Hoshide; T Mitsuhashi; U Ikeda; S Nishiuma; M Matsuo; K Shimada
Journal:  J Am Coll Cardiol       Date:  1998-08       Impact factor: 24.094

8.  Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme.

Authors:  S Ueda; H L Elliott; J J Morton; J M Connell
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

9.  Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism.

Authors:  A H Danser; M A Schalekamp; W A Bax; A M van den Brink; P R Saxena; G A Riegger; H Schunkert
Journal:  Circulation       Date:  1995-09-15       Impact factor: 29.690

10.  Angiotensin II. Adrenergic sympathetic constrictor action in humans.

Authors:  D Lyons; J Webster; N Benjamin
Journal:  Circulation       Date:  1995-03-01       Impact factor: 29.690

View more
  4 in total

1.  Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle.

Authors:  Seema Mital; Wendy K Chung; Steven D Colan; Lynn A Sleeper; Cedric Manlhiot; Cammon B Arrington; James F Cnota; Eric M Graham; Michael E Mitchell; Elizabeth Goldmuntz; Jennifer S Li; Jami C Levine; Teresa M Lee; Renee Margossian; Daphne T Hsu
Journal:  Circulation       Date:  2011-05-16       Impact factor: 29.690

2.  Vascular dysfunction precedes hypertension associated with a blood pressure locus on rat chromosome 12.

Authors:  Sasha Z Prisco; Jessica R C Priestley; Brian D Weinberg; Anthony R Prisco; Matthew J Hoffman; Howard J Jacob; Michael J Flister; Julian H Lombard; Jozef Lazar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-22       Impact factor: 4.733

3.  Phenotype-genotype interactions on renal function in type 2 diabetes: an analysis using structural equation modelling.

Authors:  X Y Song; S Y Lee; R C W Ma; W Y So; J H Cai; C Tam; V Lam; W Ying; M C Y Ng; J C N Chan
Journal:  Diabetologia       Date:  2009-05-29       Impact factor: 10.122

4.  Norepinephrine as a potential aggravator of symptomatic cerebral vasospasm: two cases and argument for milrinone therapy.

Authors:  F A Zeiler; J Silvaggio; A M Kaufmann; L M Gillman; M West
Journal:  Case Rep Crit Care       Date:  2014-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.